IP Verse

Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia - EP2925324B1

PatentPatent Analysis

EP2925324

RICHTER GEDEON NYRT
Application Number
EP13805597A
Filing Date
Nov 28, 2013
Status
Granted And Under Opposition
Nov 27, 2020
Grant Date
Dec 30, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3877395B1
EP2828396B1
EP3212667B1

Bibliography

The patent EP2925324B1 was granted to Richter Gedeon Nyrt on Dec 30, 2020 following the initial filing on Nov 28, 2013 under the application number EP13805597A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KRKASep 30, 2021ADMISSIBLE
WITTKOPPSep 29, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents